サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420394

養殖用飼料および医薬品の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、種別、地域別

Aquaculture Feed and Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 202 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
養殖用飼料および医薬品の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、種別、地域別
出版日: 2024年01月22日
発行: Fairfield Market Research
ページ情報: 英文 202 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の養殖用飼料および医薬品の市場規模は、2024年には9億9,940万米ドルになるとみられています。これらの製品に対する需要は世界的に安定しており、年間平均成長率（CAGR）は7.4％と予測されています。その結果、市場は2031年末には20億米ドルに達する見込みです。

世界の養殖用飼料および医薬品市場は、医薬品と生物製剤の分野における継続的な進歩と研究によって、2031年まで大きく成長する態勢が整っています。最近の市場分析によると、医薬品・生物製剤セグメントは、金額と成長の両面でこの業界の支配的な勢力として台頭し、生物製剤サブセグメントは予測期間中、CAGR7.7%という驚異的な数字を記録し、他を圧倒すると予想されています。

様々な製品タイプの中で、医薬品・生物製剤セグメントは市場魅力度指数1.6を誇る最も有利なセグメントとなります。これとは対照的に、薬用飼料セグメントは市場魅力度指数0.4と、最も魅力に欠けると予想されます。

当レポートでは、世界の養殖用飼料および医薬品市場について調査し、市場の概要とともに、製品タイプ別、種別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の養殖用飼料および医薬品市場の見通し、2018年～2031年

  • 世界の養殖用飼料および医薬品市場の見通し、製品タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界の養殖用飼料および医薬品市場の見通し、種別、金額（10億米ドル）、2018年～2031年
  • 世界の養殖用飼料および医薬品市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米の養殖用飼料および医薬品市場の見通し、2018年～2031年

第5章 欧州の養殖用飼料および医薬品市場の見通し、2018年～2031年

第6章 アジア太平洋の養殖用飼料および医薬品市場の見通し、2018年～2031年

第7章 ラテンアメリカの養殖用飼料および医薬品市場の見通し、2018年～2031年

第8章 中東・アフリカの養殖用飼料および医薬品市場の見通し、2018年～2031年

第9章 競合情勢

  • 製品タイプ別と種別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Zoetis, Inc.
    • Schouw & Co
    • Ridley Corporation Ltd
    • Merck & Co Inc
    • Biomin Holding GmbH
    • Aller Aqua A/S
    • Nutriad Ltd.
    • Alltech Inc.
    • Avanti Feeds Ltd.
    • Norel S.A.
    • Cargill, Incorporated
    • Beneo GmbH
    • Skretting AS

第10章 付録

目次

The global market size for aquaculture feed and pharmaceuticals is currently estimated to be at US$ 999.4 million in 2024. It is anticipated that there will be a steady demand for these products worldwide, with a projected Compound Annual Growth Rate (CAGR) of 7.4%. As a result, the market is expected to reach a valuation of US$ 2 billion by the conclusion of 2031.

The global aquaculture feed and pharmaceuticals market is poised for significant growth through 2031, driven by continuous advancements and research in the field of pharmaceuticals and biologics. A recent market analysis indicates that the pharmaceutical and biologics segment will emerge as the dominant force in this industry, both in terms of value and growth with the biologics sub-segment expected to outperform others, boasting an impressive 7.7% compound annual growth rate (CAGR) during the forecast period.

Most Lucrative Segment with Strong Market Attractiveness

Among various product types, the pharmaceutical and biologics segment is set to be the most lucrative, boasting a market attractiveness index of 1.6. In contrast, the medicated feed segment is expected to be the least attractive, with a market attractiveness index of 0.4.

Driving Factors Behind Market Growth

Several factors are fueling the growth of the pharmaceutical and biologics segment in the aquaculture feed and pharmaceuticals market. There is a growing demand for structured research and development in the aquaculture field, particularly in biologics research. This has led to a faster introduction of drugs, medicated feed, and vaccines into regional markets, particularly in developed countries such as the United States and Canada. Such initiatives have stimulated inorganic growth through strategic partnerships and M&A activities among key industry players.

Key Trends and Developments

In the United States, the use of extra label drugs in aquaculture, under the guidance of licensed veterinarians, has opened up opportunities for the development of medicated feed and pharmaceuticals. Regulatory bodies, such as the FDA, support the use of approved extra label aquaculture medicated feeds, provided they meet compliance conditions. This development is expected to expand the scope for further advancements in medicated feed and pharmaceuticals for aquaculture.

Furthermore, the demand for in-feed medication as a prophylactic measure is on the rise in the global aquaculture feed and pharmaceutical market. The adoption of in-feed medication to prevent the spread of diseases among healthy fish is growing, particularly in organized fishing farms across Europe. This trend aligns with the limited use of antibiotics in the region.

Governmental Collaborations Drive R&D

Governments in various countries are initiating collaborative research and development efforts in partnership with regulatory bodies to enhance the availability of high-quality medicated feed and pharmaceuticals for aquaculture. As aquaculture becomes a crucial source of food for human consumption, the need for safe and effective treatments for various fish diseases has grown significantly.

Challenges Ahead

Despite the growth prospects, the lack of harmonization of veterinary medicinal products and medicated feed regulations across different regions, particularly in the European Union, poses challenges. Different laws for manufacturing veterinary medicines and medicated feed, along with varying residue limits of veterinary medicines in feed, hinder market estimation and forecasting efforts.

Competitive Analysis:

Some of the prominent players in the global market for aquaculture feed & pharmaceutical market are:

  • Zoetis, Inc.
  • Schouw & Co
  • Ridley Corporation Ltd
  • Merck & Co Inc
  • Biomin Holding GmbH
  • Aller Aqua A/S
  • Nutriad Ltd.
  • Alltech Inc.
  • Avanti Feeds Ltd.
  • Norel S.A.
  • Cargill, Incorporated
  • Beneo GmbH
  • Skretting AS
  • Novus International Inc.
  • Growel Feeds Pvt. Ltd.
  • Neovia Vietnam
  • Evonik Industries AG
  • Bayer AG
  • Koninklijke DSM N.V
  • Others.

Market Segmentation

Product Type

  • Pharmaceutical and Biologics

Anti-infectives

Parasiticides

Biologics

Others

  • Medicated Feed

Vitamins and Minerals

Amino Acids

Acidifiers

Others

Species

  • Molluscs
  • Shrimp
  • Salmons
  • Carps
  • Tilapia
  • Catfish
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Aquaculture Feed and Pharmaceutical Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 3.1. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pharmaceutical and Biologics
        • 3.1.1.1.1. Anti-infectives
        • 3.1.1.1.2. Parasiticides
        • 3.1.1.1.3. Biologics
        • 3.1.1.1.4. Others
      • 3.1.1.2. Medicated Feed
        • 3.1.1.2.1. Vitamins and Minerals
        • 3.1.1.2.2. Amino Acids
        • 3.1.1.2.3. Acidifiers
        • 3.1.1.2.4. Others
  • 3.2. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Molluscs
      • 3.2.1.2. Shrimp
      • 3.2.1.3. Salmons
      • 3.2.1.4. Carps
      • 3.2.1.5. Tilapia
      • 3.2.1.6. Catfish
      • 3.2.1.7. Others
  • 3.3. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 4.1. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Pharmaceutical and Biologics
        • 4.1.1.1.1. Anti-infectives
        • 4.1.1.1.2. Parasiticides
        • 4.1.1.1.3. Biologics
        • 4.1.1.1.4. Others
      • 4.1.1.2. Medicated Feed
        • 4.1.1.2.1. Vitamins and Minerals
        • 4.1.1.2.2. Amino Acids
        • 4.1.1.2.3. Acidifiers
        • 4.1.1.2.4. Others
  • 4.2. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Molluscs
      • 4.2.1.2. Shrimp
      • 4.2.1.3. Salmons
      • 4.2.1.4. Carps
      • 4.2.1.5. Tilapia
      • 4.2.1.6. Catfish
      • 4.2.1.7. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 5.1. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Pharmaceutical and Biologics
        • 5.1.1.1.1. Anti-infectives
        • 5.1.1.1.2. Parasiticides
        • 5.1.1.1.3. Biologics
        • 5.1.1.1.4. Others
      • 5.1.1.2. Medicated Feed
        • 5.1.1.2.1. Vitamins and Minerals
        • 5.1.1.2.2. Amino Acids
        • 5.1.1.2.3. Acidifiers
        • 5.1.1.2.4. Others
  • 5.2. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Molluscs
      • 5.2.1.2. Shrimp
      • 5.2.1.3. Salmons
      • 5.2.1.4. Carps
      • 5.2.1.5. Tilapia
      • 5.2.1.6. Catfish
      • 5.2.1.7. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Pharmaceutical and Biologics
        • 6.1.1.1.1. Anti-infectives
        • 6.1.1.1.2. Parasiticides
        • 6.1.1.1.3. Biologics
        • 6.1.1.1.4. Others
      • 6.1.1.2. Medicated Feed
        • 6.1.1.2.1. Vitamins and Minerals
        • 6.1.1.2.2. Amino Acids
        • 6.1.1.2.3. Acidifiers
        • 6.1.1.2.4. Others
  • 6.2. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Molluscs
      • 6.2.1.2. Shrimp
      • 6.2.1.3. Salmons
      • 6.2.1.4. Carps
      • 6.2.1.5. Tilapia
      • 6.2.1.6. Catfish
      • 6.2.1.7. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 7.1. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Pharmaceutical and Biologics
        • 7.1.1.1.1. Anti-infectives
        • 7.1.1.1.2. Parasiticides
        • 7.1.1.1.3. Biologics
        • 7.1.1.1.4. Others
      • 7.1.1.2. Medicated Feed
        • 7.1.1.2.1. Vitamins and Minerals
        • 7.1.1.2.2. Amino Acids
        • 7.1.1.2.3. Acidifiers
        • 7.1.1.2.4. Others
  • 7.2. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Molluscs
      • 7.2.1.2. Shrimp
      • 7.2.1.3. Salmons
      • 7.2.1.4. Carps
      • 7.2.1.5. Tilapia
      • 7.2.1.6. Catfish
      • 7.2.1.7. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Pharmaceutical and Biologics
        • 8.1.1.1.1. Anti-infectives
        • 8.1.1.1.2. Parasiticides
        • 8.1.1.1.3. Biologics
        • 8.1.1.1.4. Others
      • 8.1.1.2. Medicated Feed
        • 8.1.1.2.1. Vitamins and Minerals
        • 8.1.1.2.2. Amino Acids
        • 8.1.1.2.3. Acidifiers
        • 8.1.1.2.4. Others
  • 8.2. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Molluscs
      • 8.2.1.2. Shrimp
      • 8.2.1.3. Salmons
      • 8.2.1.4. Carps
      • 8.2.1.5. Tilapia
      • 8.2.1.6. Catfish
      • 8.2.1.7. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Species Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Zoetis, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Schouw & Co
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Ridley Corporation Ltd
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Merck & Co Inc
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Biomin Holding GmbH
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Aller Aqua A/S
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Nutriad Ltd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alltech Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Avanti Feeds Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Norel S.A.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Cargill, Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Beneo GmbH
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Skretting AS
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations